Showing results (31-40 of 121) with videos related to
Sort By:
Pageof 13
Annals of Surgery|June 30, 2016
Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the PatientsThilo Hackert, Milena Sachsenmaier, Ulf Hinz, et al.BMC Cancer|February 5, 2014
A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patientsSusanne Blank, Sivaramakrishna Rachakonda, Gisela Keller, et al.Nature Reviews. Clinical Oncology|March 18, 2023
Neoadjuvant therapy for pancreatic cancerChristoph Springfeld, Cristina R Ferrone, Matthew H G Katz, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2011
Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysisTanner S Miest, Koon-Chu Yaiw, Marie Frenzke, et al.Human Gene Therapy|May 7, 2013
Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccineChristian Grossardt, Christine E Engeland, Sascha Bossow, et al.World Journal of Surgical Oncology|April 19, 2015
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinomaDaniel Habermehl, Ingo C Brecht, Frank Bergmann, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 2, 2018
Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRIViktoria Palm, Ruofan Sheng, Philipp Mayer, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 4, 2019
Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survivalUlrike Heger, Huihui Sun, Ulf Hinz, et al.Targeted Oncology|April 20, 2026
Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX DatabaseLena Dreikhausen, Alexander Olkus, Michael Dill, et al.BMJ Open|August 23, 2019
Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe studySusanne Roth, Christoph Springfeld, Markus K Diener, et al.Pageof 13